Skip to main content
COVID-19 | Childhood | Vaccines

Building Confidence in COVID-19 Vaccines for Younger Children

Last Updated 11/17/2021

Given the recent Emergency Use Authorization for COVID-19 vaccination of children ages 5-11, the COVID-19 Vaccine Education and Equity Project convened a webinar aimed at addressing key questions and considerations related to younger children and the vaccine. A panel of health experts discussed how the clinical trials were conducted for this age group, the regulatory approval process that was followed and addressed parents’ top questions to help build confidence in the vaccine for children 5-11.

Participants included:

This discussion was moderated by Dr. Lucy McBride, Practicing Internal Medicine Physician.

Vaccines | Childhood | COVID-19

COVID-19 Vaccine Considerations for Back-to-School Season

Last Updated 08/04/2021

With children 12 years of age and older eligible for COVID-19 vaccination and families gearing up for the start of a new school season, the COVID-19 Vaccine Education and Equity Project convened a webinar intended to answer commons questions about the vaccine and provide parents with the information they need to include vaccination as part of their school-ready checklist on August 3rd.

Confirmed participants included:

Vaccines | Childhood | COVID-19

Addressing Adolescent Camp & Sports Safety

Last Updated 07/02/2021

With summer camps, sports leagues and the rollout of vaccines for adolescents underway across the country, the COVID-19 Vaccine Education and Equity Project convened a discussion around building confidence in and ways to increase access to vaccines for children age 12-17 on July 1st.

Speakers included:

Sue Peschin, President and CEO of Alliance for Aging Research and co-convener of the COVID-19 Vaccine Education Equity Project moderated the discussion.

Vaccines | Childhood | COVID-19

Exploring the COVID-19 Vaccine Development and Approval Process for Adolescents

Watch CVEEP’s webinar featuring a panel of pediatric and family medicine experts discussing how the clinical trials were done for 12-15 year-olds, the regulatory approval process that was followed and addressing parents’ top questions to help build confidence in the vaccine for adolescents.
Last Updated 05/28/2021

Watch the “Exploring the COVID-19 Vaccine Development and Approval Process for Adolescents” webinar featuring a panel of pediatric and family medicine experts discussing how the clinical trials were done for 12-15 year-olds, the regulatory approval process that was followed and addressing parents’ top questions to help build confidence in the vaccine for adolescents. Panelists included:

Beth Battaglino, RN-C, CEO of HealthyWomen and a co-convener of the project moderated this discussion.